Paolo Marchetti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice	FRONTIERS IN ONCOLOGY	2021
Prediction of recurrence by Machine learning in salivary gland cancer patients after adjuvant (chemo)radiotherapy	IN VIVO	2021
Role of chemotherapy in vulvar cancers: time to rethink standard of care?	CANCERS	2021
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy	JOURNAL OF THORACIC ONCOLOGY	2021
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients	CELL DEATH & DISEASE	2021
Impact of sarcopenia and inflammation on patients with advanced non-small cell lung cancer (Ncscl) treated with immune checkpoint inhibitors (icis): a prospective study	CANCERS	2021
Statins and immunotherapy. Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC	CANCER REPORTS	2021
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort	JOURNAL OF TRANSLATIONAL MEDICINE	2021
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care. a national survey	SUPPORTIVE CARE IN CANCER	2021
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy	JOURNAL FOR IMMUNOTHERAPY OF CANCER	2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study	BIOMARKER RESEARCH	2021
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial	SCIENTIFIC REPORTS	2021
Circulating hpv dna in the management of oropharyngeal and cervical cancers: Current knowledge and future perspectives	JOURNAL OF CLINICAL MEDICINE	2021
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors among Patients Aged 80 Years or Older with Cancer: A Multicenter International Cohort Study	JAMA ONCOLOGY	2021
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting	THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY	2021
Global mapping of cancers: The Cancer Genome Atlas and beyond	MOLECULAR ONCOLOGY	2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study	BIOMARKER RESEARCH	2021
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab	ANNALS OF HEMATOLOGY	2021
'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation' by Braaten et al: another point of view	ANNALS OF THE RHEUMATIC DISEASES	2020
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: the Italian NSCLC expanded access program	LUNG CANCER	2020